股票行情快报：天臣医疗（688013）2月25日主力资金净卖出512.44万元

Group 1 - The core viewpoint of the article highlights the financial performance and stock activity of Tianchen Medical (688013) as of February 25, 2026, showing a slight increase in stock price and notable changes in fund flows [1][2]. - As of February 25, 2026, Tianchen Medical's stock closed at 43.82 yuan, with a trading volume of 8,433 hands and a total transaction amount of 36.88 million yuan [1]. - In terms of fund flow on February 25, 2026, the main funds experienced a net outflow of 512.44 thousand yuan, while retail investors saw a net inflow of 387.24 thousand yuan [1]. Group 2 - For the first three quarters of 2025, Tianchen Medical reported a main revenue of 244 million yuan, reflecting a year-on-year increase of 20.66%, and a net profit attributable to shareholders of 71.95 million yuan, up 68.29% year-on-year [2]. - The third quarter of 2025 alone saw a main revenue of 87.66 million yuan, which is a 26.4% increase compared to the same quarter last year, and a net profit of 23.73 million yuan, marking a 70.74% year-on-year rise [2]. - The company maintains a debt ratio of 11.3% and a gross profit margin of 63.22%, indicating strong financial health [2].